Search research articles
Contact Us
Filters
Showing results (41-50 of 4,010) with videos related to
Page
of 401
Sort By:
Medicina Y Cirugia De Guerra
|
March 19, 2010
Historical note on health tactics
F ARTEAGA PASTOR
Journal of the History of Biology
|
August 30, 2024
"The Logic of Monsters:" Pere Alberch and the Evolutionary Significance of Experimental Teratology
Juanma Sánchez Arteaga
Experimental Cell Research
|
March 22, 2003
ErbB-targeted therapeutic approaches in human cancer
Carlos L Arteaga
Breast Cancer Research : BCR
|
March 13, 2003
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
Carlos L Arteaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
Molecular therapeutics: is one promiscuous drug against multiple targets better than combinations of molecule-specific drugs?
Carlos L Arteaga
Revista Medica De Chile
|
April 11, 2017
[Menopause and cardiovascular risk]
Eugenio Arteaga Urzúa
Cancer Biology & Therapy
|
September 26, 2003
Inhibiting tyrosine kinases: successes and limitations
Carlos L Arteaga
Journal of Mammary Gland Biology and Neoplasia
|
March 8, 2000
Foundations of molecular therapies in breast carcinoma
C L Arteaga
Breast Cancer Research : BCR
|
April 5, 2011
ERBB receptors in cancer: signaling from the inside
Carlos L Arteaga
Revista Medica De Chile
|
July 31, 2020
Óscar Arteaga Herrera
Page
of 401
Search research articles
Search
Showing results (41-50 of 4,010) with videos related to
Sort By:
Page
of 401
Medicina Y Cirugia De Guerra
|
March 19, 2010
Historical note on health tactics
F ARTEAGA PASTOR
Journal of the History of Biology
|
August 30, 2024
"The Logic of Monsters:" Pere Alberch and the Evolutionary Significance of Experimental Teratology
Juanma Sánchez Arteaga
Experimental Cell Research
|
March 22, 2003
ErbB-targeted therapeutic approaches in human cancer
Carlos L Arteaga
Breast Cancer Research : BCR
|
March 13, 2003
Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
Carlos L Arteaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2003
Molecular therapeutics: is one promiscuous drug against multiple targets better than combinations of molecule-specific drugs?
Carlos L Arteaga
Revista Medica De Chile
|
April 11, 2017
[Menopause and cardiovascular risk]
Eugenio Arteaga Urzúa
Cancer Biology & Therapy
|
September 26, 2003
Inhibiting tyrosine kinases: successes and limitations
Carlos L Arteaga
Journal of Mammary Gland Biology and Neoplasia
|
March 8, 2000
Foundations of molecular therapies in breast carcinoma
C L Arteaga
Breast Cancer Research : BCR
|
April 5, 2011
ERBB receptors in cancer: signaling from the inside
Carlos L Arteaga
Revista Medica De Chile
|
July 31, 2020
Óscar Arteaga Herrera
Page
of 401